Yalinay, D. Et Al. 2018. A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience.. Acta neurologica Belgica , vol.118, no.3 , 475-484.

Yalinay, D., Kosak, S., Ilgaz, A., & Sagduyu, K., (2018). A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience.. Acta neurologica Belgica , vol.118, no.3, 475-484.

Yalinay, PİNAR Et Al. "A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience.," Acta neurologica Belgica , vol.118, no.3, 475-484, 2018

Yalinay, PİNAR Y. Et Al. "A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience.." Acta neurologica Belgica , vol.118, no.3, pp.475-484, 2018

Yalinay, D. Et Al. (2018) . "A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience.." Acta neurologica Belgica , vol.118, no.3, pp.475-484.

@article{article, author={PİNAR YALİNAY DİKMEN Et Al. }, title={A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience.}, journal={Acta neurologica Belgica}, year=2018, pages={475-484} }